5-Year survival in Danish patients with advanced non-small cell lung cancer treated with immune checkpoint inhibitor monotherapy-Reference-Cited by-同舟云学术

5-Year survival in Danish patients with advanced non-small cell lung cancer treated with immune checkpoint inhibitor monotherapy

Published:2023-08-03 Issue:8 Volume:62 Page:861-870
ISSN:0284-186X
Container-title:Acta Oncologica
language:en
Short-container-title:Acta Oncologica

Author:

Bjørnhart Birgitte¹²³⁴^ORCID,Mouritzen Mette Thune⁵⁶⁷^ORCID,Kristiansen Charlotte⁸^ORCID,Schytte Tine¹²⁴^ORCID,Wedervang Kim⁹^ORCID,Pøhl Mette¹⁰,Holmskov Hansen Karin¹²³

Affiliation:

1. Department of Oncology, Odense University Hospital, Odense, Denmark

2. Department of Clinical Research, University of Southern Denmark, Odense, Denmark

3. OPEN, Odense Patient Data Explorative Network, Odense University Hospital, Odense, Denmark

4. Academy of Geriatric Cancer Research (AgeCare), Odense University Hospital, Odense, Denmark

5. Department of Clinical Medicine, Aalborg University Hospital, Aalborg East, Denmark

6. Department of Oncology, Aalborg University Hospital, Aalborg, Denmark

7. Clinical Cancer Research Centre, Aalborg University Hospital, Aalborg, Denmark

8. Department of Oncology, Vejle Hospital, Vejle, Denmark

9. Department of Oncology, Hospital Soenderjylland Soenderborg, Soenderborg, Denmark

10. Department of Oncology, Rigshospitalet, Copenhagen, Denmark

Funder

Dansk kræftforskningsfond

Axel Muusfeldts fond

Publisher

Medical Journals Sweden AB

Subject

Radiology, Nuclear Medicine and imaging,Oncology,Hematology,General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/0284186X.2023.2238544

Reference30 articles.

1. The Danish Cancer Society. Report: Kræft i Danmark. The Danish Cancer Society; 2022. Available from: http://www.cancer.dk.

2. DLCG/DOLG. Annual report of lung cancer in the Danish population 2021 (DLCG. Årsrapport 2021); 2022. Available from: http://www.lungecancer.dk/Lungecancer_-aarsrapport-2021offentlig.pdf.

3. Comparison of Four Chemotherapy Regimens for Advanced Non–Small-Cell Lung Cancer

4. Phase III Study Comparing Cisplatin Plus Gemcitabine With Cisplatin Plus Pemetrexed in Chemotherapy-Naive Patients With Advanced-Stage Non–Small-Cell Lung Cancer

5. Annual Report to the Nation on the status of cancer, 1975‐2010, featuring prevalence of comorbidity and impact on survival among persons with lung, colorectal, breast, or prostate cancer

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Effects of Demographic and Socio-Economic Factors on Investigation Time of Lung Cancer Patients in Denmark: A Retrospective Cohort Study;Health Services Research and Managerial Epidemiology;2023-01